UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin— influence on treatment outcome

The American journal of gastroenterology, 1998-03, Vol.93 (3), p.386-389

1998

Volltextzugriff (PDF)

Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori

Infection and Immunity, 1996-09, Vol.64 (9), p.3491-3496

1996

Volltextzugriff (PDF)

Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection

The American journal of gastroenterology, 1995-01, Vol.90 (1), p.168-169

1995

Volltextzugriff (PDF)

Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome

The American journal of gastroenterology, 1998-03, Vol.93 (3), p.386-389

1998

Volltextzugriff (PDF)

Biochemical studies of Helicobacter mustelae fatty acid composition and flagella

Infection and Immunity, 1992-04, Vol.60 (4), p.1695-1698

1992

Volltextzugriff (PDF)

Successful Helicobacter pylori eradication: a systemic effect of antibiotics?

The American journal of gastroenterology, 1993-05, Vol.88 (5), p.792-793

1993

Volltextzugriff (PDF)

Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect

The American journal of gastroenterology, 1994-09, Vol.89 (9), p.1602-1603

1994

Volltextzugriff (PDF)

Cloning and characterization of a new type of fimbria (S/F1C-related fimbria) expressed by an Escherichia coli O75:K1:H7 blood culture isolate

Infection and Immunity, 1988-11, Vol.56 (11), p.2918-2924

1988

Volltextzugriff (PDF)

Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein

Infection and Immunity, 1987-10, Vol.55 (10), p.2416-2419

1987

Volltextzugriff (PDF)

Antibody-independent interaction of the first component of complement with Gram-negative bacteria

Infection and Immunity, 1978-10, Vol.22 (1), p.5-9

1978

Volltextzugriff (PDF)

Sulbactam and clavulanic acid: studies of enzyme kinetics and synergy with ampicillin and mezlocillin

Drugs (New York, N.Y.), 1988, Vol.35 Suppl 7 (Supplement 7), p.71-76

1988

Volltextzugriff (PDF)

Isolation and separation of physicochemically distinct fimbrial types expressed on a single culture of Escherichia coli O7:K1:H6

Infection and Immunity, 1985-02, Vol.47 (2), p.549-554

1985

Volltextzugriff (PDF)

Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes

The Journal of immunology (1950), 1975-10, Vol.115 (4), p.1028

1975

Volltextzugriff (PDF)

Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy

The American journal of gastroenterology, 1994, Vol.89 (1), p.39-42

1994

Volltextzugriff (PDF)

Three-dimensional structure of fimbriae determines specificity of immune response

Infection and Immunity, 1985-11, Vol.50 (2), p.517-522

1985

Volltextzugriff (PDF)

Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study

The American journal of clinical nutrition, 1978-10, Vol.31 (10), p.1821-1826

1978

Volltextzugriff (PDF)

Cure of Helicobacter pylori infection : role of duration of treatment with omeprazole and amoxicillin

The American journal of gastroenterology, 1996, Vol.91 (1), p.98-100

1996

Volltextzugriff (PDF)

Double-blind cross-over study with oral α-ketoacids in patients with chronic renal failure

The American journal of clinical nutrition, 1980-07, Vol.33 (7), p.1678-1681

1980

Volltextzugriff (PDF)

Evidence for macrophage C3d-receptor active in phagocytosis

The Journal of immunology (1950), 1975-05, Vol.114 (5), p.1643

1975

Volltextzugriff (PDF)

Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4

The Journal of immunology (1950), 1971-04, Vol.106 (4), p.927

1971

Volltextzugriff (PDF)

Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. II. Clustering of effective C42 complexes at individual hemolytic sites

The Journal of immunology (1950), 1971-02, Vol.106 (2), p.407

1971

Volltextzugriff (PDF)

C2 Hypocomplementaemia in multiple sclerosis

The Lancet (British edition), 1976-12, Vol.2 (7999), p.1358

1976

Volltextzugriff (PDF)

C2 HYPOCOMPLEMENTÆMIA IN MULTIPLE SCLEROSIS

The Lancet (British edition), 1976-12, Vol.308 (7999), p.1358-1359

1976

Volltextzugriff (PDF)

The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime

Arzneimittel-Forschung, 1991-08, Vol.41 (8), p.831

1991

Volltextzugriff (PDF)

Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study12

The American journal of clinical nutrition, 1978-10, Vol.31 (10), p.1821-1826

1978

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(15)
Biological And Medical Sciences
(9)
Female
(8)
Immunology
(8)
Male
(8)
Adult
(7)
Middle Aged
(7)
Bacteriology
(6)
Drug Therapy, Combination
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Gastroenterology & Hepatology
(6)
Helicobacter Infections - Drug Therapy
(6)
Helicobacter Pylori
(6)
Infectious Diseases
(6)
Microbiology
(6)
Animals
(5)
Aged
(4)
Morphology, Structure, Chemical Composition
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin— influence on treatment outcome

Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori

Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection

Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome

Biochemical studies of Helicobacter mustelae fatty acid composition and flagella

Successful Helicobacter pylori eradication: a systemic effect of antibiotics?

Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect

Cloning and characterization of a new type of fimbria (S/F1C-related fimbria) expressed by an Escherichia coli O75:K1:H7 blood culture isolate

Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein

Antibody-independent interaction of the first component of complement with Gram-negative bacteria

Sulbactam and clavulanic acid: studies of enzyme kinetics and synergy with ampicillin and mezlocillin

Isolation and separation of physicochemically distinct fimbrial types expressed on a single culture of Escherichia coli O7:K1:H6

Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes

Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy

Three-dimensional structure of fimbriae determines specificity of immune response

Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study

Cure of Helicobacter pylori infection : role of duration of treatment with omeprazole and amoxicillin

Double-blind cross-over study with oral α-ketoacids in patients with chronic renal failure

Evidence for macrophage C3d-receptor active in phagocytosis

Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4

Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. II. Clustering of effective C42 complexes at individual hemolytic sites

C2 Hypocomplementaemia in multiple sclerosis

C2 HYPOCOMPLEMENTÆMIA IN MULTIPLE SCLEROSIS

The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime

Treatment with essential amino acids in patients on chronic hemodialysis: a double blind cross-over study12

Aktive Filter

Suchergebnisse filtern